Correct Answer: C. HBsAg
HBsAg (Hepatitis B surface antigen) is historically called the Australia antigen because it was first discovered in 1965 in the serum of an Australian Aboriginal patient with hepatitis B. This discovery predated the identification of HBV itself and became the first serological marker used for HBV detection. HBsAg is the outer envelope protein of the hepatitis B virus and is the most reliable marker for acute and chronic HBV infection. In Indian clinical practice, HBsAg detection forms the cornerstone of HBV screening—it appears first during acute infection (within 30–60 days of exposure) and persists in chronic carriers. The presence of HBsAg indicates active HBV infection and infectivity. According to Indian guidelines (NACO, IAP), all blood donors, pregnant women, and healthcare workers are screened for HBsAg. The antigen is produced in excess by infected hepatocytes and circulates as free particles and immune complexes. Its detection by ELISA is the standard diagnostic test in India, and HBsAg positivity mandates further testing (HBeAg, anti-HBc, HBV-DNA) to assess disease stage and infectivity.
Why the other options are wrong
A. HBV-DNA — HBV-DNA is the viral genome and indicates active viral replication, not the Australia antigen. While HBV-DNA is more specific for active replication and is used to assess viral load and guide antiviral therapy in India, it was not the first discovered marker and is not historically called Australia antigen. It appears later than HBsAg and requires PCR detection, making it less practical for routine screening. B. HBeAg — HBeAg (Hepatitis B e antigen) is a marker of active viral replication and high infectivity, but it is NOT the Australia antigen. HBeAg appears after HBsAg during acute infection and its presence correlates with HBV-DNA levels. In Indian clinical practice, HBeAg is used to stratify chronic HBV patients for treatment eligibility, but historically it was identified much later than HBsAg and has no connection to the Australia antigen nomenclature. D. HBcAg — HBcAg (Hepatitis B core antigen) is the internal capsid protein and is not found free in serum—it is detected only in liver tissue or as anti-HBc antibodies in serum. HBcAg is not the Australia antigen. While anti-HBc is a useful marker of past or present HBV infection in India, HBcAg itself is not routinely detected in blood and was not the first discovered marker of hepatitis B.
High-Yield Facts
- HBsAg (Australia antigen) was first discovered in 1965 in an Australian Aboriginal patient and is the outer envelope protein of HBV.
- HBsAg appears 30–60 days after HBV exposure and is the earliest detectable marker of acute infection in Indian screening protocols.
- HBsAg positivity indicates active HBV infection and infectivity; its presence mandates further testing with HBeAg, anti-HBc, and HBV-DNA in India.
- NACO and IAP guidelines recommend HBsAg screening for all blood donors, pregnant women, healthcare workers, and patients undergoing surgery in India.
- HBsAg detection by ELISA is the standard, cost-effective, and widely available diagnostic test in Indian laboratories and blood banks.
Mnemonics
Australia Antigen = Surface Antigen Australia = Antigen (HBsAg) — the outer surface protein discovered in an Australian patient. Remember: surface = first discovered, first detected, most abundant. HBV Marker Timeline HBsAg → Anti-HBc → HBeAg → HBV-DNA — HBsAg appears first (30–60 days), making it the Australia antigen and the primary screening marker in India.
NBE Trap
NBE may pair "Australia antigen" with HBeAg or HBV-DNA to trap students who confuse active replication markers with the historical first-discovered surface antigen. The key discriminator is the 1965 discovery in an Australian patient—only HBsAg fits this historical fact.
Clinical Pearl
In Indian blood banks and antenatal clinics, HBsAg is the first and often only test performed due to cost and availability. A positive HBsAg in a pregnant woman triggers vertical transmission prevention protocols (HBIG + HBV vaccine for the neonate), making this antigen clinically critical for maternal-child health in India.
_Reference: Jawetz Melnick & Adelberg's Medical Microbiology Ch. 43; Harrison's Principles of Internal Medicine Ch. 295 (Hepatitis B)_